| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/23/2002 | CA2428716A1 Method to identify genes associated with chronic myelogenous leukemia |
| 05/23/2002 | CA2428709A1 Association of calpain inhibitors and reactive oxygen species trapping agents |
| 05/23/2002 | CA2428707A1 Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration |
| 05/23/2002 | CA2428249A1 Combination therapy for estrogen-dependent disorders |
| 05/23/2002 | CA2428136A1 Modified clostridial neurotoxins with altered biological persistence |
| 05/23/2002 | CA2427902A1 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 05/23/2002 | CA2427896A1 Carrier vectors through an epithelium with tight junctions |
| 05/23/2002 | CA2427207A1 Multipurpose packages for sterilised products or products to be sterilised |
| 05/23/2002 | CA2427010A1 Transporters and ion channels |
| 05/23/2002 | CA2426521A1 Treatment of sexual dysfunction using bombesin antagonist |
| 05/23/2002 | CA2420983A1 Molecules for disease detection and treatment |
| 05/22/2002 | EP1207200A1 High affinity choline transporter |
| 05/22/2002 | EP1207199A1 Tumor antigen |
| 05/22/2002 | EP1207198A1 Novel g protein-coupled receptor protein and dna thereof |
| 05/22/2002 | EP1207197A1 Antifungic compositions and method for controlling fungi |
| 05/22/2002 | EP1207169A1 Novel g protein-coupled receptor protein and dna thereof |
| 05/22/2002 | EP1206941A1 Activity potentiators for chemotherapeutics, anticancer compositions and method for potentiating the activity of chemotherapeutics |
| 05/22/2002 | EP1206911A1 Growth promoting compositions for mammals and method of promoting the growth of mammals by using the same |
| 05/22/2002 | EP1206582A1 Methods and compositions for inhibition of membrane fusion-associated events, including hiv transmission |
| 05/22/2002 | EP1206578A2 Bdnf polymorphism and association with bipolar disorder |
| 05/22/2002 | EP1206577A2 Binary encoded sequence tags |
| 05/22/2002 | EP1206576A1 Novel kinases and uses thereof |
| 05/22/2002 | EP1206573A1 26 human secreted proteins |
| 05/22/2002 | EP1206563A1 Genetically altered dendritic cells transduced with adeno-associated virus (aav), methods of producing said cells and uses thereof |
| 05/22/2002 | EP1206557A2 Plant defensin variants |
| 05/22/2002 | EP1206554A1 Activatable recombinant neurotoxins |
| 05/22/2002 | EP1206553A2 Isomerase proteins |
| 05/22/2002 | EP1206548A1 Basb118 polypeptide and polynucleotide from moraxella catarrhalis |
| 05/22/2002 | EP1206544A2 Odorant-binding human proteins fixing hydrophobic ligands: polypeptides and polynucleotides coding for said polypeptides and uses thereof |
| 05/22/2002 | EP1206543A2 Membrane associated proteins |
| 05/22/2002 | EP1206541A1 Dendritic enriched secreted lymphocyte activation molecule |
| 05/22/2002 | EP1206540A2 Dna sequences isolated from human colonic epithelial cells |
| 05/22/2002 | EP1206539A2 Medicament for the prevention and/or the treatment of ischemic heart and peripheral vascular diseases, tumour and wounds |
| 05/22/2002 | EP1206529A2 UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-BETA 1,3-N-ACETYLGALACTOSAMINE-ALPHA-R/(GlcNAc to GalNAc) BETA 1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2GnT3 |
| 05/22/2002 | EP1206527A1 Treatment of inflammatory or malignant disease using dnazymes |
| 05/22/2002 | EP1206492A2 Self-aligning peptides derived from human elastin and other fibrous proteins |
| 05/22/2002 | EP1206491A1 Tgf-beta receptor polynucleotides, polypeptides, and antibodies |
| 05/22/2002 | EP1206490A1 Vegf-d and angiogenic use thereof |
| 05/22/2002 | EP1206489A2 Orally active peptides that prevent cell damage and death |
| 05/22/2002 | EP1206488A2 Method for isolating and purifying grass pollen allergens |
| 05/22/2002 | EP1206487A2 Notch receptor ligands and uses thereof |
| 05/22/2002 | EP1206485A2 New effectors of dipeptidyl peptidase iv for topical use |
| 05/22/2002 | EP1206484A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 05/22/2002 | EP1206478A1 Antisense modulation of mekk5 expression |
| 05/22/2002 | EP1206449A1 Lactam inhibitors of hepatitis c virus ns3 protease |
| 05/22/2002 | EP1206444A1 Compounds that inhibit tryptase activity |
| 05/22/2002 | EP1206313A1 Preparation of a therapeutic composition |
| 05/22/2002 | EP1206285A2 Drug-carrier complexes and methods of use thereof |
| 05/22/2002 | EP1206279A1 Method for treating tnf-receptor type-2-induced diseases |
| 05/22/2002 | EP1206278A2 Peptide mixture and vaccine against a chronic viral infection |
| 05/22/2002 | EP1206276A2 Tissue volume reduction |
| 05/22/2002 | EP1206275A2 Irrigation solution and method for inhibition of pain and inflammation |
| 05/22/2002 | EP1206274A2 Use of interleukin-18 inhibitors to inhibit tumor metastasis |
| 05/22/2002 | EP1206273A2 Peptides that block viral infectivity and methods of use thereof |
| 05/22/2002 | EP1206272A1 Hybrid polypeptides with enhanced pharmacokinetic properties |
| 05/22/2002 | EP1206271A1 Composition and method for enhancing wound healing |
| 05/22/2002 | EP1206266A2 Formulations for parenteral use of estramustine phosphate and albumin |
| 05/22/2002 | EP1206261A2 Pharmaceutical compositions comprising clavulanic acid or derivative thereof for the treatment of behavioral diseases |
| 05/22/2002 | EP1206259A2 Use of substance p antagonists for the treatment of adenocarcinoma |
| 05/22/2002 | EP1206257A1 Use of amino acids for making medicines for treating to insulin-resistance |
| 05/22/2002 | EP1206254A1 Drug releasing biodegradable fiber implant |
| 05/22/2002 | EP1206251A1 Amplification of folate-mediated targeting to tumor cells using nanoparticles |
| 05/22/2002 | EP1206245A2 Phospholipid gel |
| 05/22/2002 | EP1206234A2 Methods and compositions for modulating cell proliferation and cell death |
| 05/22/2002 | EP1206233A2 Serine proteases |
| 05/22/2002 | EP1107996B1 HUMAN ANTI-FACTOR IX/IXa ANTIBODIES |
| 05/22/2002 | EP1049487B1 Treatment of acute intermittent porphyria (aip) and other porphyric diseases |
| 05/22/2002 | EP0894093B1 Soluble tachykinin antagonists, the preparation and use thereof |
| 05/22/2002 | EP0797431B1 Aerosol formulations of peptides and proteins |
| 05/22/2002 | EP0665754B1 Antimicrobial peptides |
| 05/22/2002 | EP0452364B1 Method for preparing water soluble polypeptides |
| 05/22/2002 | EP0437599B1 Cell lineages expressing a biologically active factor ix |
| 05/22/2002 | CN1350592A Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms |
| 05/22/2002 | CN1350583A Recombinant platelet collagen receptor Glycoprotein VI and its pharmaceutical use |
| 05/22/2002 | CN1350578A Recombinant influenza viruses for vaccines and gene therapy |
| 05/22/2002 | CN1350548A Long lasting insulinotropic peptides |
| 05/22/2002 | CN1350547A Alleviation of the alelrgenic potential of airborne and contact allergens by thioredoxin |
| 05/22/2002 | CN1350546A 结核诊断测验 TB diagnostic test |
| 05/22/2002 | CN1350545A Spray drying of thrombin inhibitors |
| 05/22/2002 | CN1350519A Reversible aqueous pH Sensitive lipidizing reagents, compositions and methods of use |
| 05/22/2002 | CN1350464A Docetaxel in combination with rhumab HER2 for the treatment of cancers |
| 05/22/2002 | CN1350463A A Pharmaceutical formulation containing an inhibitor of carboxypeptidase U and a thrombin inhibitor |
| 05/22/2002 | CN1350445A Treatment of hepatitis C using hyperthermia |
| 05/22/2002 | CN1350002A Deformed streptococcus adherence resisting polypeptide mixture |
| 05/22/2002 | CN1349828A Beautifying health oral liquid containing cell regulating factor and its making process |
| 05/22/2002 | CN1349827A Human tumor necrosis factor-alpha oral prepn. of marine polychlorella |
| 05/22/2002 | CN1349820A Application of shinyleaf yellowhorn fruit shell in preparing cerbral function improving food and medicine |
| 05/21/2002 | USRE37710 Radiometal-binding analogues of luteinizing hormone releasing hormone |
| 05/21/2002 | US6392046 Aids therapy |
| 05/21/2002 | US6392029 HIV chemokines |
| 05/21/2002 | US6392028 Functional DNA clone for hepatitis C virus (HCV) and uses thereof |
| 05/21/2002 | US6392025 Human NHE3 protein and non-human cells expressing same |
| 05/21/2002 | US6392023 Nucleotide sequences which codes preferential polypeptide for use in serodiagnostics and vaccine development |
| 05/21/2002 | US6392020 Monoclonal antibody to the clonotypic structure of a T-cell receptor, a pharmaceutical compostion and a diagnostic reagent comprising the same |
| 05/21/2002 | US6392019 Immunoglobulins for use in human therapeutics and diagnostics for use in treatment of cancer |
| 05/21/2002 | US6392018 Polypeptides for use in the treatment of pathologies associated with inflammatory respone, nervous system disorders and leukemias; for use as a molecular weight control; for use in foods |
| 05/21/2002 | US6392013 Redirection of cellular immunity by protein tyrosine kinase chimeras |
| 05/21/2002 | US6392012 Glycopeptide derivatives and pharmaceutical compositions containing the same |
| 05/21/2002 | US6391919 Aids therapy |
| 05/21/2002 | US6391869 Compositions and methods for the treatment of anorectal disorders |